Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (Q37259057)
Jump to navigation
Jump to search
scientific article published on September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology |
scientific article published on September 2008 |
Statements
1 reference
Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (English)
1 reference
Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
1 reference
D S Goodin
1 reference
B A Cohen
1 reference
P O'Connor
1 reference
L Kappos
1 reference
J C Stevens
1 reference
1 September 2008
1 reference
Identifiers
1 reference